‘devastating’ for efforts to stop HIV and will cost many lives of the world’s most vulnerable people. But she also proposed an ‘amazing deal’ for US President Donald Trump that, she said, could result in ‘the end of AIDS’.

At a news briefing in Geneva, UNAIDS Executive Director Winnie Byanyima said that the deal would involve Trump enabling the US company Gilead to produce and license its ‘magical’ prevention drug, lenacapavir, across the world to the millions of people who need it.

Lenacapavir, sold as Sunlenca, has been shown through twice-yearly injections to completely prevent HIV infection in women and which works nearly as well in men. “President Trump likes deals,” Byanyima said, acknowledging that it was President George W. Bush who first started paying for the widespread roll-out of HIV drugs more than two decades ago. (Jamaica Gleaner/AP)